66 studies found for:    "Ebola virus disease"
Show Display Options
Rank Status Study
1 Completed Experimental Vaccine for Prevention of Ebola Virus Infection
Conditions: Ebola Hemorrhagic Fever;   Ebola Virus Disease;   Ebola Virus Vaccines;   Envelope Glycoprotein, Ebola Virus;   Filovirus
Intervention: Drug: VRC-EBOADV018-00-VP
2 Completed Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
3 Enrolling by invitation A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease
Condition: Acute Ebola Virus Disease
Intervention: Biological: INTERCEPT Plasma
4 Not yet recruiting Multiple Treatments for Ebola Virus Disease (EVD)
Condition: Ebola Virus Disease
Interventions: Drug: Azithromycin;   Drug: Sunitinib and Erlotinib;   Drug: Atorvastatin and Irbesartan;   Other: IV fluids and laboratory testing
5 Completed Ebola and Marburg Virus Vaccines
Conditions: Ebola Vaccines;   Marburg Virus Disease;   Ebola Virus Disease;   Marburgvirus;   Ebolavirus
Interventions: Drug: VRC-EBODNA023-00-VP;   Drug: VRC-MARDNA025-00-VP
6 Completed Efficacy of Favipiravir Against Severe Ebola Virus Disease
Condition: Ebola Virus Disease
Interventions: Other: WHO-recommended therapies;   Drug: Favipiravir
7 Recruiting Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
Condition: Ebola Virus Disease
Intervention:
8 Active, not recruiting Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Condition: Ebola Virus Disease
Interventions: Biological: Ebola Vaccine - low dose;   Biological: Ebola Vaccine - mid dose;   Biological: Ebola Vaccine - high dose;   Biological: Placebo
9 Completed A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Condition: Ebola Virus Disease
Interventions: Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: High dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: placebo (one dose);   Biological: placebo (two doses)
10 Recruiting A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo
Conditions: Ebola;   Ebola Zaire
Interventions: Biological: cAd3-EBO Z at 1 x 10^10 vp;   Biological: cAd3-EBO Z at 2.5 x 10^10 vp;   Biological: cAd3-EBO Z at 5 x 10^10 vp;   Biological: 4.4x10^8 TCID50s MVA-BN® Filo;   Biological: 2.2x10^8 TCID50s MVA-BN® Filo;   Biological: 4.4 x 10^7 TCID50s MVA-BN® Filo
11 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
12 Withdrawn Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Condition: Ebola Virus Disease
Interventions: Drug: Best Supportive Care;   Drug: Best Supportive Care + Amiodarone
13 Completed Evaluation of the FilmArray BioThreat-E Test
Condition: Ebola Virus Disease
Intervention:
14 Completed Evaluating an Ebola and a Marburg Vaccine in Uganda
Conditions: Ebola Virus Disease;   Marburg Virus Disease
Interventions: Biological: Ebola vaccine;   Biological: Marburg vaccine;   Other: Placebo injection
15 Active, not recruiting Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Interventions: Biological: VRC-EBOADC069-00-vp;   Biological: MVA-EbolaZ;   Other: Placebo
16 Active, not recruiting Phase 1 Trial of Ebola Vaccine in Mali
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Interventions: Biological: Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z;   Biological: Booster-MVA-BN® Filo or saline placebo
17 Active, not recruiting A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV
Condition: Ebola Virus Disease
Interventions: Biological: ChAd3-EBO-Z;   Biological: Ad26.ZEBOV
18 Active, not recruiting A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus Disease
Intervention: Biological: VSV-ZEBOV
19 Recruiting Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
Condition: Ebola Virus
Interventions: Biological: VSVG-ZEBOV;   Biological: ChAd3-EBO Z;   Drug: Placebo
20 Withdrawn An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
Condition: Ebola Virus
Intervention: Drug: CMX001

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years